Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Seoul
Clinical trial register · South Korea

Clinical Trials in Seoul, 2026

Every study on the ClinicalTrials.gov registry that lists a site in South Korea and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3401 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:18 UTC
3401
Studies in scope
all four open statuses
1867
Recruiting now
open to new participants
507
Lead sponsors
across recruiting studies
Top sites
Seoul 2859 Daegu 553 Seongnam-si 482 Busan 469 Goyang-si 397
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca197 Seoul National University Hospital184 Yonsei University148 Samsung Medical Center147 Merck Sharp & Dohme LLC114 Novartis Pharmaceuticals88 Janssen Research & Development, LLC81 Hoffmann-La Roche70 Asan Medical Center69 AbbVie62 Pfizer58 Eli Lilly and Company58 GlaxoSmithKline56 Bristol-Myers Squibb40 Amgen35 Sanofi32 Boehringer Ingelheim31 Korea University Anam Hospital30 Gilead Sciences27 Regeneron Pharmaceuticals27 Daiichi Sankyo26 Novo Nordisk A/S23 Daewoong Pharmaceutical Co. LTD.21 Takeda21 Gangnam Severance Hospital20 Show all 627
Site location
Seoul2859 Daegu553 Seongnam-si482 Busan469 Goyang-si397 Incheon349 Suwon337 Daejeon214 Gyeonggi-do211 Gwangju208 Seongnam206 Cheongju-si186 Yangsan123 Bucheon-si111 Jeonju92 Wŏnju90 Hwasun85 Ulsan81 Ansan-si61 Jinju55 Goyang52 Anyang-si52 Chuncheon48 Pusan42 Hwasun-gun41 Show all 259
All 259 locations
Target enrolment
to

Trials with a site in Seoul

2859 of 3401 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in South Korea
Start
Not yet open
Alexion Pharmaceuticals, Inc.
Phase 3
1,180
Seoul, Busan
2027-11-23
Not yet open
OPTIA-AF Trial: Rhythm-Guided Antithrombotic Strategy After AF Ablation
NCT07496281Atrial Fibrillation (AF), Coronary Artery Disease, Drug-eluting Stent
Ewha Womans University Mokdong Hospital
Phase 4
2
Seoul
2027-03-01
Not yet open
ENCell
Phase 1/2
132
Seoul
2027-03-01
Not yet open
Kyoung Hwan Koh
Not applicable
38
Seoul
2027-02-01
Not yet open
Boehringer Ingelheim
Phase 3
1,500
Anyang, Cheongju-si, Daegu, Dong-gu Ulsan, Incheon, Seoul, Wŏnju
2027-01-11
Not yet open
Novo Nordisk A/S
Phase 3
400
Seoungnam-si, Suwon, Yangsan, Daegu, Seoul
2027-01-07
Not yet open
An AI-ECG-Based Approach for Dynamic Assessment of Heart Failure Risk and Myocardial Recovery Following Atrial Fibrillation Ablation
NCT07708818Atrial Fibrillation (AF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
Ewha Womans University Mokdong Hospital
Observational
1,000
Seoul
2027-01-01
Not yet open
ER-VISION-AI Study
NCT07727590Chest Pain, Dyspnea, Acute Cardiopulmonary Disease, Emergency Department Patients
Ewha Womans University Mokdong Hospital
Not applicable
1,000
Seoul
2027-01-01
Not yet open
Sung-il Cho
Not applicable
300
Seoul
2027-01
Not yet open
Intuitive Surgical
Observational
151
Goyang-si, Daejeon, Seoul, Ulsan
2027-01
Not yet open
1ST Biotherapeutics, Inc.
Phase 1
72
Seoul
2027-01
Not yet open
Duk-Woo Park, MD
Not applicable
2,500
Seoul
2026-12-30
Not yet open
Seoul National University Dental Hospital
Phase 2
36
Seoul
2026-12-30
Not yet open
AstraZeneca
Phase 3
204
Daegu, Seoul, Wŏnju
2026-12-21
Not yet open
Bristol-Myers Squibb
Phase 3
2,380
Namdong-gu, Bucheon-si, Goyang-si, Suwon, Busan, Haeundae-gu, Seoul, Dong-gu, Ulsan
2026-12-16
Not yet open
Boehringer Ingelheim
Phase 3
270
Gwangju, Seoul
2026-12-14
Not yet open
Boehringer Ingelheim
Phase 1
200
Seoul
2026-12-07
Not yet open
COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE"
NCT07281027New Onset Refractory Status Epilepticus, New-Onset Refractory Status Epilepticus, Febrile Infection-Related Epilepsy Syndrome (FIRES)
DrugsAnakinra·Tocilizumab
Yale University
Phase 3
438
Seoul
2026-12-01
Recruiting
EOI Block in Otoplasty With Rib Cartilage Graft
NCT07262944Postoperative Pain, Acute
Seoul National University Hospital
Not applicable
60
Seoul
2026-12-01
Not yet open
HealthMpowerment Korea: Pilot Testing the Cultural Adaptation of a Digital HIV Intervention for Men Who Have Sex With Men in South Korea
NCT07741123HIV Infections, HIV Prevention and Care, Risk Reduction Behavior, Digital Health
Seul Ki Choi
Not applicable
50
Seoul
2026-12-01
Not yet open
FENOX Trial (Comparative Effectiveness of Fexuprazan Co-therapy in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants)
NCT07497893Atrial Fibrillation (AF), Upper Gastrointestinal Bleeding (UGIB), Gastrointestinal Hemorrhage (Clinically Important, Upper), Drug-Related Side Effects and Adverse Reactions
DrugZastaprazan
Ewha Womans University Mokdong Hospital
Not applicable
1,000
Seoul
2026-12-01
Not yet open
Bristol-Myers Squibb
Phase 2
80
Seoul
2026-11-30
Not yet open
Dong-A University Hospital
Not applicable
60
Busan, Seongnam-si, Seoul
2026-11-29
Not yet open
Smartphone Camera Measurement of Breathing-Related Heart Rate Variability Compared With ECG in Healthy Adults
NCT07922161Respiratory Sinus Arrhythmia, Heart Rate Variability, Healthy Volunteers
BELL Therapeutics Inc.
Not applicable
36
Seoul
2026-11-23
Not yet open
Efficacy and Safety of Adalimumab for the Treatment of Ocular Inflammation
NCT07913750Non-infectious Anterior Uveitis, Non-infectious Intermediate Uveitis, Non-infectious Posterior Uveitis, Panuveitis
Samsung Medical Center
Not applicable
40
Seoul
2026-11-15
Not yet open
Boehringer Ingelheim
Phase 2
70
Seoul
2026-11-13
Not yet open
Novo Nordisk A/S
Phase 3
1,408
Anyang-si, Bucheon-si, Seongnam-si, Yangsan, Busan, Daegu, Daejeon, Seoul
2026-11-11
Not yet open
Novo Nordisk A/S
Phase 3
450
Wŏnju, Bucheon-si, Gwangju, Seoul
2026-11-10
Not yet open
Novo Nordisk A/S
Phase 3
1,060
Ansan-si, Yongin-si, Busan, Daegu, Seoul, Ulsan
2026-11-10
Not yet open
Comparison of Fractional FLOW Reserve Outcomes With Drug-Coated Balloon-Based Versus Drug-Eluting Stent-Only Percutaneous Coronary Intervention Strategies
NCT07852689Coronary Artery Disease, Percutaneous Coronary Intervention, Drug Coated Balloon, Drug Eluting Stents (DES)
Korea University Guro Hospital
Not applicable
100
Seoul
2026-11-09
Recruiting
Videoconference-Based Brief Cognitive Behavioral Therapy for Patients With Mood Disorders at High Risk for Suicide
NCT07857291Suicidal Ideation and Behavior, Mood Disorders, Suicide Attempt, Cognitive Behavior Therapy
Hyung Keun Park
Not applicable
320
Seoul
2026-11-04
Recruiting
Chemotherapy With or Without IMD10 (Focused Ultrasound) in the Treatment of Borderline Resectable or Locally Advanced Pancreatic Cancer
NCT07325214Pancreatic Cancer, Borderline Resectable Pancreatic Cancer, Locally Advanced Pancreatic Cancer
IMGT Co., Ltd.
Not applicable
366
Gyeonggi-do, Seoul
2026-11-04
Recruiting
Sung-Han Kim
Phase 2
60
Seoul
2026-11-02
Recruiting
Yonsei University
Observational
20
Seoul
2026-11-01
Not yet open
Edoxaban Versus Apixaban in Cancer-Associated Venous Thromboembolism
NCT07852637Venous Thromboembolism, Active Cancer
DrugsEdoxaban·Apixaban
Samsung Medical Center
Phase 4
2,300
Goyang-si, Busan, Goyang, Gwangmyeong, Hwasun, Jeonju, Seoul
2026-11-01
Not yet open
Effects of Remimazolam on Postoperative Cognitive Dysfunction and Neuroinflammatory Biomarkers in Patients Undergoing Aortic Arch Surgery
NCT07816068Aortic Aneurysm of the Proximal Arch, Aortic Aneurysms Arch, Aortic Arch Disease, Postoperative Delirium (POD)
DrugsRemimazolam Besylate·Propofol
Seoul National University Hospital
Phase 4
80
Seoul
2026-11-01
Not yet open
Asan Medical Center
Not applicable
20
Seoul
2026-11-01
Not yet open
Yonsei University
Phase 2
69
Seoul
2026-11
Not yet open
AJU Pharm Co., Ltd.
Phase 1
60
Seoul
2026-11
Not yet open
Yonsei University
Not applicable
10
Seoul
2026-11
Not yet open
AJU Pharm Co., Ltd.
Phase 1
40
Seoul
2026-11
Not yet open
Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)
NCT07521670Recurrent Adenoid Cystic Carcinoma, Adenoid Cystic Carcinoma Metastatic, Papillary Thyroid Carcinoma
DrugSacituzumab tirumotecan
National Cancer Centre, Singapore
Phase 2
68
Gyeonggi-do, Seoul
2026-11
Not yet open
InSightec
Not applicable
120
Seoul
2026-11
Not yet open
Bristol-Myers Squibb
Observational
10
Seoul
2026-10-31
Recruiting
Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
NCT07473700Hypertension, Pulmonary, Lung Diseases, Interstitial
Tectonic Operating Company, Inc.
Phase 2
25
Gyeonggi-do, Seoul
2026-10-30
Not yet open
Remimazolam Concentration and Sedation Depth During Lower Extremity Surgery Under Spinal Anesthesia
NCT07863063Sedation During Lower Extremity Surgery Under Spinal Anesthesia
DrugRemimazolam
Seoul National University Hospital
Phase 4
60
Seoul
2026-10-30
Not yet open
Agentic AI App and Home Bioimpedance Monitoring for Endocrine Therapy Adherence and Lymphedema in Breast Cancer Survivors
NCT07911839Breast Neoplasm Malignant Primary, Lymphedema Arm, Medication Adherence, Ductal Carcinoma In Situ
Chang-Ik Yoon
Not applicable
264
Seoul
2026-10-29
Not yet open
Seo-hee Lee
Not applicable
172
Seoul
2026-10-28
Recruiting
Patient-controlled Remimazolam Sedation Under Spinal Anesthesia
NCT07661810Hip Arthroplasty, Spinal Anesthesia, Remimazolam, Patient-controlled Sedation
Seoul National University Hospital
Not applicable
104
Seoul
2026-10-26
Recruiting
Yuhan Corporation
Phase 1
44
Seoul
2026-10-20
Recruiting
Eli Lilly and Company
Phase 3
1,000
Ansan-si, Gwangju, Seongnam, Seoul
2026-10-16
Recruiting
PULSAR Radiotherapy Combined With Immunotherapy for High-Risk Advanced Liver Cancer
NCT07884877Hepatocellular Carcinoma (HCC), Radiotherapy-Induced Immune Priming, Immunotherapy
DrugNivolumab
Samsung Medical Center
Phase 2
38
Seoul
2026-10-15
Not yet open
Zastaprazan for the prEvention of Upper GI Bleeding in Ischemic Stroke
NCT07730840Ischemic Stroke, Transient Ischemic Attack
DrugZastaprazan
Asan Medical Center
Phase 3
984
Daejeon, Gwangju, Gyeonggi-do, Incheon, Jeju City, Jeonju, Seoul
2026-10-15
Recruiting
LigaChem Biosciences, Inc.
Phase 1/2
191
Seoul
2026-10-14
Not yet open
HK inno.N Corporation
Phase 1
34
Seoul
2026-10-14
Not yet open
Asan Medical Center
Observational
100
Seoul
2026-10-13
Recruiting
Merck Sharp & Dohme LLC
Phase 2
15
Seoul
2026-10-13
Recruiting
GI Innovation, Inc.
Phase 1/2
107
Seoul
2026-10-12
Recruiting
AIMEDBIO
Phase 1
86
Seoul
2026-10-09
Recruiting
Txinno Bioscience Inc.
Phase 1/2
104
Gyeonggi-do, Incheon, Seoul
2026-10-08
Recruiting
Jung-min Ahn
Not applicable
2,034
Seoul
2026-10-06
Recruiting
Samsung Medical Center
Phase 2
20
Seoul
2026-10-06
Recruiting
Hoffmann-La Roche
Phase 3
400
Seongnam-si, Busan, Daegu, Daejeon, Gyeonggi-do, Incheon, Jeollanam-do, Seoul
2026-10-06
Recruiting
GlaxoSmithKline
Phase 3
720
Seoul
2026-10-02
Recruiting
Effect of Remimazolam Versus Propofol Total Intravenous Anesthesia on Intraoperative Hemodynamic Stability in Patients Undergoing Thoracic or Abdominal Endovascular Aortic Repair
NCT07806006Aortic Aneurysm, Thoracoabdominal, Aortic Aneurysm, Abdominal, Intraoperative Hypotension, Hemodynamic Instability During Anesthesia
DrugsRemimazolam Besylate·Propofol
Seoul National University Hospital
Phase 4
44
Seoul
2026-10-01
Not yet open
Wonshik Han
Not applicable
1,520
Seoul
2026-10-01
Not yet open
Post-marketing Surveillance Study for the Safety of Efluelda Tetra Pre-filled Syringe.
NCT06694025Immunization, Influenza (Healthy Volunteers)
Sanofi
Observational
670
Seoul
2026-10-01
Not yet open
BMI Korea
Phase 1
72
Seoul, Suwon
2026-10-01
Not yet open
Huons Co., Ltd.
Phase 1
30
Seoul
2026-10
Not yet open
PULSTA TPV Observational Study
NCT07747207Heart Disease
Taewoong Medical Co., Ltd.
Observational
200
Bucheon-si, Seoul
2026-10
Not yet open
GC Biopharma Corp
Phase 2/3
1,806
Seoul
2026-10
Recruiting
Immunogenicity and Safety of Respiratory Syncytial Virus Vaccine in Lung Transplant Recipients
NCT07895394Vaccination, Respiratory Syncytial Virus (RSV), Lung Transplant Recipient
Seoul National University Hospital
Phase 4
80
Seoul
2026-10
Not yet open
Woo-Keun Seo
Not applicable
1,626
Seoul
2026-09-30
Recruiting
Corbus Pharmaceuticals Inc.
Phase 3
260
Busan, Jeonju, Seongnam, Seongnam-si, Seoul, Suwon, Yangsan
2026-09-29
Recruiting
Korea University Guro Hospital
Not applicable
100
Seoul
2026-09-29
Recruiting
Patient-Specific MRD Liquid Biopsy in Resected NSCLC: Plasma and Bronchial Washing ctDNA
NCT07921888Non-Small Cell Lung Cancer, Minimal Residual Disease
Eun Hye Lee
Observational
40
Yongin-si, Seoul
2026-09-28
Active, closed
Sahmyook University
Not applicable
44
Seoul
2026-09-28
Recruiting
Eli Lilly and Company
Phase 3
150
Seongnam-si, Seoul
2026-09-25
Recruiting
AstraZeneca
Phase 3
750
Seoul
2026-09-24
Recruiting
Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer
NCT07816666Platinum-sensitive Relapsed Epithelial Ovarian Cancer, Platinum-sensitive Relapsed Fallopian Tube Cancer, Platinum-sensitive Relapsed Primary Peritoneal Cancer
DrugsTorvutatug samrotecan·Bevacizumab
AstraZeneca
Phase 3
600
Goyang-si, Seoul
2026-09-24
Recruiting
Novartis Pharmaceuticals
Phase 3
382
Hwaseong-si, Suwon, Seoul
2026-09-21
Recruiting
Takeda
Observational
35
Suwon, Seoul
2026-09-21
Recruiting
Influenza Vaccine Immunogenicity in Repeatedly Vaccinated Older Adults
NCT07838298Influenza Vaccination, Older Adults (65 Years and Older), Immunosenescence, Immunogenicity
DrugInfluenza vaccine
Korea University Guro Hospital
Phase 4
180
Seoul
2026-09-21
Recruiting
Merck Sharp & Dohme LLC
Phase 3
802
Seoul
2026-09-18
Active, closed
Associations of Postoperative Hemoglobin With AKI-AKD Trajectories
NCT07907198Patients Undergoing Valvular Heart Surgery
Yonsei University
Observational
4,230
Seoul
2026-09-18
Recruiting
Boehringer Ingelheim
Phase 3
466
Bucheon-si, Gyeonggi-do, Busan, Seongnam, Seoul
2026-09-17
Recruiting
BREZTRI REGULATORY POST MARKETING SURVEILLANCE IN KOREA
NCT07570394Chronic Obstructive Pulmonary Disease (COPD), Asthma
AstraZeneca
Observational
600
Chuncheon, Daegu, Goyang-si, Gwangmyeong, Jinju, Seongnam-si, Seoul, Wŏnju
2026-09-17
Recruiting
Daiichi Sankyo
Phase 1/2
220
Seongnam-si, Seoul
2026-09-17
Recruiting
Post-marketing Surveillance Study for the Safety of Efluelda® Pre-filled Syringe
NCT07282795Influenza Immunization, Healthy Volunteers
DrugEfluelda
Sanofi
Observational
670
Goyang-si, Gunpo, Busan, Daegu, Incheon, Seoul
2026-09-17
Recruiting
AstraZeneca
Phase 3
950
Busan, Daegu, Goyang-si, Gyeonggi-do, Seongnam-si, Seoul, Yangsan
2026-09-16
Recruiting
AstraZeneca
Phase 3
1,330
Daegu, Goyang-si, Seoul
2026-09-15
Recruiting
Safety and Efficacy of NDTx-03 in Children and Adolescents With ASD or SCD
NCT07770867Autism Spectrum Disorder, Social Communication Disorder
Neudive Inc.
Not applicable
156
Daegu, Iksan, Seoul, Yangsan
2026-09-15
Recruiting
CD19 CAR-T Therapy for Refractory Childhood-Onset Systemic Lupus Erythematosus
NCT07855302Childhood-Onset Systemic Lupus Erythematosus, Refractory SLE, CD19 CAR-T Cell Therapy
Seoul National University Hospital
Phase 1
8
Seoul
2026-09-14
Recruiting
CellinCells
Observational
31
Seoul
2026-09-11
Recruiting
Vividion Therapeutics, Inc.
Phase 2
140
Seongnam-si, Gyeonggi-do, Jongno -Gu, Seoul
2026-09-11
Recruiting
Takeda
Phase 3
324
Seoul, Seongnam-si, Daegu
2026-09-10
Recruiting
Janssen Research & Development, LLC
Phase 3
1,000
Gyeonggi-do, Jeollanam-do, Seoul, Ulsan
2026-09-09
Recruiting
GlaxoSmithKline
Phase 3
690
Seoul
2026-09-08
Recruiting
Incyte Corporation
Phase 3
426
Busan, Seongnam-si, Seoul
2026-09-08
Recruiting
Samsung Bioepis Co., Ltd.
Phase 1
174
Busan, Cheongju-si, Seoul
2026-09-04
Recruiting
Autologous Adipose-Derived Stem Cell Injections for Knee Osteoarthritis
NCT07901790Osteoarthritis, Knee, Knee Osteoarthritis
DrugSynovian
Yonsei University
Not applicable
165
Incheon, Seoul
2026-09-03
Recruiting
Huons Biopharma
Phase 3
390
Seoul
2026-09-03
Recruiting
Prospective Evaluation of AI Generated History of Present Illness Drafts in the Emergency Department
NCT07804407All Emergency Department Visits Meeting Eligibility Criteria
Yonsei University
Observational
100
Seoul
2026-09-01
Not yet open
LucasBio
Phase 1/2
42
Seoul, Daegu, Goyang-si, Hwasun, Ulsan
2026-09-01
Recruiting
AstraZeneca
Phase 3
2,800
Anyang, Cheonan-si, Seoul, Wŏnju, Yangsan
2026-09-01
Recruiting
GlaxoSmithKline
Phase 3
684
Seoul, Gyeonggi-do
2026-09-01
Recruiting
Rapport Therapeutics Inc.
Phase 3
312
Seoul
2026-09-01
Not yet open
Gangnam Severance Hospital
Not applicable
280
Seoul
2026-09-01
Recruiting
Sungkyunkwan University
Not applicable
3
Seoul
2026-09-01
Not yet open
Seoul National University Childrens Hospital
Not applicable
44
Seoul
2026-09-01
Recruiting
Oslo University Hospital
Observational
400
Seoul
2026-09
Not yet open
Remote Exercise Program for Pediatric ICU Survivors
NCT07741942Pediatric Post-Intensive Care Syndrome, Critical Illness
Seoul National University Hospital
Not applicable
10
Seoul
2026-09
Recruiting
A Phase 1 Study of ATORM-C in Patients With Crohn's Disease
NCT07822087Crohn's Diseases, Crohn's Disease
ORGANOIDSCIENCES LTD.
Phase 1
18
Seoul
2026-09
Not yet open
Huons Co., Ltd.
Phase 1
28
Seoul
2026-09
Recruiting
GlaxoSmithKline
Phase 2
274
Pusan, Seoul
2026-08-31
Recruiting
Samsung Medical Center
Not applicable
40
Seoul
2026-08-31
Recruiting
AstraZeneca
Phase 3
1,072
Seoul
2026-08-31
Not yet open
Effect of Mechanical Power-based Lung-protective Ventilation During One-lung Ventilation
NCT07772804Lung Cancer (Diagnosis), Pulmonary Complications in Surgical Patients
Samsung Medical Center
Not applicable
164
Seoul
2026-08-30
Recruiting
Regeneron Pharmaceuticals
Phase 3
1,600
Yongin-si, Busan, Seoul
2026-08-26
Recruiting
Intravenous Dexamethasone With Single-Shot Versus Continuous Brachial Plexus Block for Rebound Pain After Shoulder Surgery
NCT07699744Pain, Postoperative, Rebound Pain, Shoulder Injuries, Rotator Cuff Injuries
DrugDexamethasone
Seoul National University Hospital
Phase 4
92
Seoul
2026-08-25
Recruiting
Novartis Pharmaceuticals
Phase 3
180
Ansan, Seoul
2026-08-24
Not yet open
Seoul National University Hospital
Not applicable
3,000
Seongnam-si, Uijeongbu-si, Daegu, Seoul
2026-08-24
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
DrugElecoglipron
AstraZeneca
Phase 3
6,950
Busan, Daegu, Daejeon, Gwangju, Gyeonggi-do, Incheon, Seongbuk-Gu, Seoul
2026-08-24
Recruiting
AstraZeneca
Phase 3
7,000
Anyang-si, Busan, Cheonan-si, Daejeon, Goyang-si, Guri-si, Junggu, Seoul
2026-08-21
Recruiting
AstraZeneca
Phase 3
1,500
Busan, Daegu, Daejeon, Incheon, Seoul, Suwon
2026-08-20
Not yet open
Chong Kun Dang Pharmaceutical
Phase 1
76
Seoul
2026-08-20
Recruiting
AstraZeneca
Phase 3
2,500
Anyang, Bucheon-si, Daegu, Seoul, Yangsan
2026-08-19
Recruiting
SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors
NCT07812805Selected Advanced Solid Tumors, Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Biliary Tract Cancer (BTC)
SK Life Science, Inc.
Phase 1
100
Seoul
2026-08-19
Not yet open
Hallym University Kangnam Sacred Heart Hospital
Not applicable
100
Seoul
2026-08-17
Not yet open
Angiotensin Receptor Blocker After TAVR in Severe Aortic Stenosis With Left Ventricular Hypertrophy (ARBITAR)
NCT07735130Transcatheter Aortic Valve Replacement (TAVR), Left Ventricular Hypertrophy, Severe Aortic Stenosis
Seoul National University Hospital
Phase 4
632
Seoul
2026-08-15
Recruiting
Eli Lilly and Company
Phase 3
1,000
Ansan-si, Gwangju, Jeju City, Seoul
2026-08-14
Recruiting
Samsung Medical Center
Not applicable
66
Seoul
2026-08-14
Recruiting
STEPwise De-escalation and Optimizing Withdrawal of ARNI and SGLT2i in Normalized Heart Failure
NCT07631156Heart Failure With Reduced Ejection Fraction, Heart Failure, Ventricular Dysfunction, Left
Kyungsub Song
Phase 4
80
Daegu, Seongnam-si, Suwon, Yangsan, Seoul
2026-08-12
Recruiting
CellinCells
Phase 1/2
31
Seoul
2026-08-12
By invitation
EAA-Guided AN69-oXiris and PMX-HP Therapy in Septic Patients
NCT07788144Hemoperfusion, Sepsis, ICU, Endotoxin Levels
Kyoung Moo Im
Not applicable
50
Seoul
2026-08-11
Recruiting
Asia Myelodysplastic Syndrome (MDS) Registry
NCT07355478Myelodysplastic Syndromes (MDS)
Bristol-Myers Squibb
Observational
500
Seoul
2026-08-11
Recruiting
Seoul National University Hospital
Observational
50
Seoul
2026-08-11
Active, closed
Seoul University of Buddhism
Not applicable
13
Seoul
2026-08-08
Recruiting
Eli Lilly and Company
Phase 2
606
Bupyeong-gu, Dongjak-gu, Gyeongsan-si, Seoul, Ulsan, Wŏnju
2026-08-07
Active, closed
Gilead Sciences
Phase 2
120
Seoul
2026-08-07
Recruiting
Radiotherapy and Long-term Outcomes in Early Breast Cancer With SLNB Omission
NCT07803081Breast Cancer, Early-Stage Invasive Breast Carcinoma
Samsung Medical Center
Observational
500
Seoul
2026-08-06
Recruiting
Dong-A ST Co., Ltd.
Phase 4
300
Seoul
2026-08-06
Recruiting
InThera Inc. Korea
Phase 1
30
Seoul
2026-08-06
Recruiting
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN
NCT07498335Berger Disease, Bergers Disease, IgA Nephropathy, Immunoglobulin A Nephropathy
DrugAtrasentan
Novartis Pharmaceuticals
Phase 3
28
Seoul
2026-08-06
Not yet open
CGM-Based Glycemic Analysis After ESI
NCT07280780Type 2 Diabetes (T2DM), Hyperglycemia, Radicular Pain, Spinal Stenosis
Korea University Anam Hospital
Observational
36
Seoul
2026-08-05
Recruiting
Real-World Effectiveness and Safety of Pegcetacoplan in Patients With C3G or IC-MPG: A Multi-Country Study
NCT07746895C3 Glomerulopathy (C3G), Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)
DrugPegcetacoplan
Swedish Orphan Biovitrum
Phase 4
150
Daegu, Daejeon, Seongnam, Seoul
2026-08-05
Recruiting
hy Co., LTD.
Not applicable
100
Seoul
2026-08-04
Recruiting
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
NCT07625644Small Cell Lung Cancer Extensive Stage, Small-cell Lung Cancer, Small Cell Carcinoma, Sclc
DrugsEtoposide·Atezolizumab·Carboplatin
SystImmune Inc.
Phase 3
550
Goyang-si, Gyeonggi-do, Jeongnam, Seoul, Suwon
2026-08-04
Recruiting
Samsung Medical Center
Not applicable
48
Seoul
2026-08-01
Not yet open
ORI-Guided Oxygen Therapy During One-Lung Ventilation
NCT07720778Thoracic Surgery With One-lung Ventilation
Konkuk University Medical Center
Not applicable
58
Seoul
2026-08-01
Not yet open
Partial Breast Irradiation Without Sentinel Lymph Node Biopsy in Low-Risk Early Breast Cancer
NCT07757958Breast Cancer, Node-negative Breast Cancer, Early-Stage Invasive Breast Carcinoma
Samsung Medical Center
Phase 3
520
Seoul
2026-08-01
Recruiting
LG Chem
Phase 4
43
Seoul
2026-08-01
Recruiting
VectivBio AG
Phase 3
124
Seoul
2026-08
Not yet open
Addpharma Inc.
Phase 1
30
Seoul
2026-08
Recruiting
Pfizer
Phase 3
336
Jeonju, Seoul
2026-07-30
Recruiting
Cellbion Co., Ltd.
Phase 1
30
Seoul
2026-07-29
Not yet open
Addpharma Inc.
Phase 1
44
Seoul
2026-07-29
Recruiting
Janssen Research & Development, LLC
Phase 2
68
Buk Gu, Busan, Seoul
2026-07-28
Recruiting
Guerbet
Phase 3
315
Seoul, Gyeonggi-do
2026-07-28
Recruiting
Bristol-Myers Squibb
Phase 2
254
Seoul
2026-07-27
Recruiting
GlaxoSmithKline
Phase 3
800
Seoul, Seongnam-si Gyeonggi-do, Suwon Kyunggi-do
2026-07-27
Recruiting
Boehringer Ingelheim
Phase 3
448
Seoul, Suwon
2026-07-27
Recruiting
MP101 in Adults With Acute Pseudomonas Aeruginosa Pneumonia
NCT07492771Pneumonia - Bacterial, Pseudomonas Aeruginosa Infection
MicrobiotiX Co., Ltd
Phase 1
18
Seoul
2026-07-25
Not yet open
Addpharma Inc.
Phase 1
74
Seoul
2026-07-24
Active, closed
Ewha Womans University
Not applicable
90
Seoul
2026-07-22
By invitation
Yonsei University
Observational
78
Seoul
2026-07-22
Recruiting
Boehringer Ingelheim
Phase 3
35
Seoul
2026-07-21
Recruiting
Insmed Incorporated
Phase 3
344
Busan, Incheon, Seoul
2026-07-21
Recruiting
Insmed Incorporated
Phase 3
344
Seoul
2026-07-20
Recruiting
Samsung Medical Center
Phase 4
3,000
Seoul
2026-07-20
Recruiting
BELL Therapeutics Inc.
Not applicable
40
Incheon, Seongnam-si, Seoul
2026-07-20
Recruiting
Kang Stem Biotech Co., Ltd.
Observational
36
Seoul
2026-07-20
Recruiting
Novartis Pharmaceuticals
Phase 3
570
Bundang Gu, Suwon, Gwangju, Seoul
2026-07-16
Recruiting
AstraZeneca
Phase 3
915
Seoul
2026-07-16
Recruiting
Prediction of Myocardial Injury After Non-Cardiac Surgery in Urologic Cancer Patients
NCT07634666Myocardial Injury After Non-cardiac Surgery, Urologic Cancer, Major Adverse Cardiovascular Events (MACE)
Korea University Anam Hospital
Observational
200
Seoul
2026-07-15
Recruiting
Samsung Medical Center
Not applicable
60
Seoul
2026-07-15
Recruiting
Seoul National University Hospital
Not applicable
30
Seoul
2026-07-15
Recruiting
Yonsei University
Phase 4
586
Seoul
2026-07-14
Recruiting
D3 Bio (Wuxi) Co., Ltd
Phase 1
24
Cheongju-si, Seoul
2026-07-14
Recruiting
MedPacto, Inc.
Observational
400
Goyang-si, Seoul
2026-07-13
Recruiting
Subchondral Drilling Diameter During CARTISTEM Implantation for Knee Cartilage Defects
NCT07881445Osteoarthritis, Knee, Articular Cartilage Defects of the Knee
Yonsei University
Not applicable
60
Seoul
2026-07-13
Active, closed
Novo Nordisk A/S
Observational
10,000
Seoul
2026-07-13
Recruiting
Boehringer Ingelheim
Phase 3
390
Seoul
2026-07-10
Not yet open
A Validation Study of the Neuro-cognitive Emotion Monitoring-Intervention (NEMO-I) Application in Adolescents
NCT07700264Adolescent Mental Health, Adolescent - Emotional Problem, Cognition Improvement
Seoul Women's University
Not applicable
140
Seoul
2026-07-10
Not yet open
Nu Eyne Co., Ltd.
Not applicable
40
Ansan, Seoul
2026-07-09
Recruiting
Routine Versus Provisional Distal Perfusion Catheter Placement in Patients Undergoing Mechanical Circulatory Support
NCT07482865Cardiogenic Shock, Acute Myocardial Infarction of Inferior Wall, Congestive Heart Failure, Myocarditis
Samsung Medical Center
Not applicable
500
Changwon, Incheon, Seoul
2026-07-08
Recruiting
AstraZeneca
Phase 3
600
Bucheon-si, Gyeonggi-do, Jongno-gu, Junggu, Seoul
2026-07-08
Recruiting
Chiesi Farmaceutici S.p.A.
Phase 2
240
Bucheon-si, Busan, Gwangju, Seoul, Suwon
2026-07-08
Recruiting
Eli Lilly and Company
Phase 3
170
Bucheon-si, Deagu, Junggu, Seongnam, Seoul
2026-07-08
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
134
Seoul
2026-07-06
Recruiting
AstraZeneca
Phase 3
1,200
Busan, Changwon-si, Daegu, Daejeon, Guri-si, Incheon, Seoul
2026-07-06
Recruiting
AstraZeneca
Phase 3
800
Jongno-gu, Seongnam-si, Seoul
2026-07-06
Recruiting
AstraZeneca
Phase 3
2,000
Busan, Goyang-si, Guri-si, Gwangju, Gyeonggi-do, Seoul, Suwon, Yangsan
2026-07-06
Recruiting
Efficacy and Safety of Eleveld PK/PD Model-based Dosing During General Anesthesia
NCT07675850Remimazolam, Pharmacokinetics and Pharmacodynamics
Seoul National University Hospital
Phase 4
68
Seoul
2026-07-05
Recruiting
Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)
NCT07387926Acute Lymphoblastic Leukemia, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
DrugsABL001·Hydrocortisone·Blinatumomab·Prednisolone
Novartis Pharmaceuticals
Phase 1/2
50
Seoul
2026-07-05
Recruiting
SK Bioscience Co., Ltd.
Phase 3
780
Daegu, Ansan, Hwaseong-si, Seongnam-si, Incheon, Seoul
2026-07-04
By invitation
Ewha Womans University Mokdong Hospital
Not applicable
482
Seoul
2026-07-03
Recruiting
Dompé Farmaceutici S.p.A
Phase 3
272
Busan, Seoul
2026-07-01
Not yet open
MedicalExcellence
Observational
1,483
Seoul
2026-07-01
Recruiting
Sanofi
Observational
706
Busan, Daegu, Goyang, Gwangju, Hanam, Iksan, Seongnam, Seoul
2026-07-01
Not yet open
A Phase 3 Study of Viloxazine ER Capsules in Korean Children and Adolescents With ADHD
NCT07678827Attention Deficit Hyperactivity Disorder, Attention-Deficit / Hyperactivity Disorder, ADHD
Alvogen Korea
Phase 3
156
Seoul
2026-07
Not yet open
Hyundai Bioscience Co., Ltd.
Phase 1
18
Seoul
2026-07
Not yet open
Addpharma Inc.
Phase 1
44
Seoul
2026-07
Not yet open
Addpharma Inc.
Phase 1
44
Seoul
2026-07
Recruiting
Huons Co., Ltd.
Phase 2
150
Seoul
2026-07
Not yet open
Bioequivalence Study of AJU-G721 and G721R in Healthy Adult Volunteers Under Fed Conditions
NCT07643233Moderate-to-severe Benign Prostatic Hyperplasia (BPH)
AJU Pharm Co., Ltd.
Phase 1
36
Seoul
2026-07
Recruiting
AbbVie
Phase 2/3
660
Seongnam-si, Seoul
2026-06-30
Recruiting
AstraZeneca
Phase 3
4,500
Busan, Daegu, Goyang-si, Gyeonggi-do, Incheon, Jongno-gu, Seoul, Suwon
2026-06-29
Recruiting
Junyeop Lee
Phase 4
64
Seongnam, Seoul
2026-06-29
Recruiting
AstraZeneca
Phase 3
750
Seoul
2026-06-26
Recruiting
Taiho Pharmaceutical Co., Ltd.
Phase 3
784
Busan, Hwasun, Seongnam, Seoul
2026-06-24
Recruiting
Samsung Medical Center
Phase 3
5,000
Seoul
2026-06-23
Recruiting
Blood Viscosity and Outcomes After Elective Craniotomy
NCT07530393Postoperative Complications, Intracranial Surgery
Asan Medical Center
Observational
1,000
Seoul
2026-06-23
Recruiting
Hoffmann-La Roche
Phase 3
380
Jeollanam-do, Seoul
2026-06-23
Recruiting
OHB Pediatrics Ltd.
Phase 3
165
Seoul
2026-06-23
Recruiting
S&Ebio Co. Ltd.
Phase 1
18
Suwon, Seoul
2026-06-22
Recruiting
Seoul National University Hospital
Phase 4
1,292
Daejeon, Seoul
2026-06-22
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
960
Seoul
2026-06-22
Recruiting
Novo Nordisk A/S
Phase 2
300
Gwangju, Seoul
2026-06-22
Recruiting
Merck Sharp & Dohme LLC
Phase 3
310
Goyang-si, Suwon, Cheongju-si, Daegu, Seoul
2026-06-18
Recruiting
GlaxoSmithKline
Phase 3
450
Seoul, Gyeonggi-do, Suwon Kyunggi-do
2026-06-18
Active, closed
Seoul National University Hospital
Observational
160
Seoul
2026-06-17
Recruiting
A Study to Evaluate DJI136, a DLL3-targeted CAR-T Therapy
NCT07564401Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Novartis Pharmaceuticals
Phase 1/2
80
Seoul
2026-06-16
Not yet open
Oxiris in Septic AKI
NCT07641660Sepsis-associated AKI
Samsung Medical Center
Not applicable
32
Seoul
2026-06-16
Recruiting
Belvarafenib for CNS Efficacy in Patients With BRAF-Altered Solid Tumors
NCT07688356Primary Brain Tumor, Metastatic Brain Tumor
DrugBelvarafenib
Samsung Medical Center
Phase 2
30
Seoul
2026-06-15
Recruiting
A Study of Iptacopan in Korean Patients With Paroxysmal Nocturnal Hemoglobinuria or C3 Glomerulopathy
NCT07416162Paroxysmal Nocturnal Hemoglobinuria, C3 Glomerulopathy
Novartis Pharmaceuticals
Observational
21
Jeollanam, Seoul
2026-06-15
Recruiting
AstraZeneca
Phase 3
150
Cheonan-si, Daegu, Goyang-si, Hwasun-eup, Incheon, Seongbuk-Gu, Seongnam-si, Seoul
2026-06-15
Recruiting
Dumping Syndrome After Esophagectomy
NCT07605481Esophagectomy, Dumping Syndrome, Continous Glucose Measurement
Samsung Medical Center
Observational
30
Seoul
2026-06-15
Recruiting
Agentic AI Personalized Dietary Management Study
NCT07638241Dietary Behavior; Metabolic Health; Obesity; Lifestyle Modification; Metabolic Syndrome Risk
Seoul National University Hospital
Not applicable
200
Seoul
2026-06-11
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
NCT07652658Idiopathic Pulmonary Fibrosis (IPF)
AstraZeneca
Phase 2
359
Seongnam-si, Seoul
2026-06-11
Recruiting
Regeneron Pharmaceuticals
Phase 3
35
Seoul
2026-06-11
Recruiting
Pfizer
Phase 3
954
Daejeon, Anyang-si, Yangsan, Incheon, Seoul
2026-06-10
Recruiting
Opiranserin for Minimally Invasive Cholecystectomy
NCT07620665Cholecystectomy, Laparoscopic, Cholecystectomy, Robotic
DrugsNSAIDs·Acetaminophen
Gangnam Severance Hospital
Not applicable
88
Seoul
2026-06-10
By invitation
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
NCT07652294Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative
DrugsSPY001·SPY002·SPY003
Spyre Therapeutics, Inc.
Phase 2
645
Wŏnju, Busan, Daegu, Daejeon, Seoul
2026-06-08
Active, closed
Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments
NCT07468071Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung Cancer, Advanced Solid Tumors Harboring the KRAS G12C Mutation
DrugsTNO155·Opnurasib·Trametinib·Cetuximab
Novartis Pharmaceuticals
Phase 1/2
25
Seoul
2026-06-08
By invitation
Prevalence and Overlap of Cardiovascular, Kidney, and Metabolic Diseases in Korea: A Population-based Study
NCT07673822Diabetes Mellitus, Type 2, Obesity, Chronic Kidney Disease, Cardiovascular Risk
Novo Nordisk A/S
Observational
800,000
Seoul
2026-06-08
Recruiting
Long-term Outcomes After Percutaneous Patent Foramen Ovale Closure (Severance PFO Registry)
NCT07724171Patent Foramen Ovale, Cryptogenic Stroke, Transient Ischemic Attack Due to Embolism, Atrial Fibrillation
Yonsei University
Observational
400
Seoul
2026-06-05
Recruiting
Asan Medical Center
Phase 4
1,058
Seoul
2026-06-05
Recruiting
Rapport Therapeutics Inc.
Phase 3
333
Busan, Seoul
2026-06-05
Recruiting
Boehringer Ingelheim
Phase 2
60
Seoul
2026-06-04
Recruiting
A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement
NCT07359820FGFR2 Gene Fusion/Rearrangement, Other Solid Tumors, Adult
Elevar Therapeutics
Phase 2
30
Seoul
2026-06-04
Recruiting
GlaxoSmithKline
Phase 3
600
Cheongju Chungcheongbuk-do, Daegu, Seongnam-si Gyeonggi-do, Seoul
2026-06-04
Recruiting
AstraZeneca
Phase 1/2
152
Seoul
2026-06-03
Recruiting
A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy
NCT07498426Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)
Novartis Pharmaceuticals
Phase 3
300
Seoul
2026-06-03
Recruiting
Dompé Farmaceutici S.p.A
Phase 3
150
Wŏnju, Gwangju, Bucheon-si, Seoul
2026-06-02
Active, closed
Seoul National University
Observational
27,000
Goyang-si, Seoul
2026-06-01
Not yet open
Seoul National University Hospital
Not applicable
140
Seoul
2026-06-01
Not yet open
Seoul National University Hospital
Phase 2
150
Seoul
2026-06-01
Recruiting
Bayer
Phase 3
117
Yangsan, Seoul
2026-06-01
Recruiting
Yonsei University
Not applicable
100
Seoul
2026-06-01
Not yet open
Seoul National University Hospital
Not applicable
292
Seoul
2026-06-01
Not yet open
Nemtabrutinib, Bortezomib, and Rituximab for WM
NCT07464210Waldenstrom Macroglobulinemia
Seoul National University Hospital
Phase 2
19
Seoul
2026-06-01
Not yet open
Naltrexone for Nonsuicidal Self-Injury
NCT07641283Nonsuicidal Self-Injury, Self-Injurious Behavior
DrugNaltrexone
Seoul National University Hospital
Not applicable
150
Uijeongbu-si, Seoul
2026-06
Not yet open
Daewoong Pharmaceutical Co. LTD.
Phase 3
510
Seoul
2026-06
Not yet open
Addpharma Inc.
Phase 1
60
Seoul
2026-06
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Goyang-si, Gyeonggi-do, Hwasun, Seoul
2026-05-31
Recruiting
D3 Bio (Wuxi) Co., Ltd
Phase 1
42
Seoul
2026-05-29
Recruiting
Innopeutics Corporation
Observational
6
Seoul
2026-05-29
Recruiting
Yonsei University
Observational
400
Seoul
2026-05-29
Recruiting
Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD
NCT07524101Renal Insufficiency, Atherosclerosis, Dyslipidemia, Hypercholesterolemia
DrugHigh-intensity statin
Yonsei University
Not applicable
1,952
Seoul
2026-05-28
Recruiting
Novartis Pharmaceuticals
Phase 1
194
Seoul
2026-05-28
Recruiting
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
NCT07101328Lymphoma, Non-Hodgkin, B-cell Lymphoma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular
Eli Lilly and Company
Phase 1
215
Seoul
2026-05-28
Recruiting
12-mm Partial Covered Versus Bare Self-Expandable Metallic Stents for Malignant Distal Biliary Obstruction
NCT07559968Malignant Distal Biliary Obstruction, Malignant Biliary Obstruction, Biliary Obstruction
Chung-Ang University Hospital
Not applicable
60
Seoul
2026-05-27
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
NCT07357727Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (PPV-MF), Post-essential Thrombocythemia Myelofibrosis (PET-MF)
DrugsPelabresib·Ruxolitinib
Novartis Pharmaceuticals
Phase 3
460
Suwon, Jeonju, Seoul, Busan
2026-05-27
Recruiting
Seoul National University Hospital
Observational
100
Seoul
2026-05-27
Not yet open
Impact of Propranolol Strategies on Myocardial Injury After Breast Cancer Surgery
NCT07583134Breast Cancer, Myocardial Injury After Noncardiac Surgery (MINS)
DrugPropranolol
Chang-Ik Yoon
Phase 4
100
Seoul
2026-05-26
Recruiting
Samsung Medical Center
Phase 2
1,173
Seoul
2026-05-26
Recruiting
Novartis Pharmaceuticals
Phase 1
208
Seoul
2026-05-25
Recruiting
Janssen Research & Development, LLC
Phase 3
644
Ansan, Busan, Daejeon, Ganggu, Seoul, Tongdaemun-Gu
2026-05-23
Recruiting
AbbVie
Phase 3
990
Busan, Incheon, Seongnam, Suwon, Hwasun-gun, Seoul
2026-05-22
Recruiting
Janssen Research & Development, LLC
Phase 3
460
Busan, Daejeon, Ganggu, Seoul
2026-05-22
Recruiting
HK inno.N Corporation
Observational
7,525
Seoul
2026-05-21
Recruiting
Regeneron Pharmaceuticals
Phase 3
270
Suwon, Hwasun, Seoul
2026-05-21
Recruiting
Hoffmann-La Roche
Phase 2/3
650
Seongnam-si, Daegu, Goyang-si, Gyeonggi-do, Seoul
2026-05-21
Recruiting
Takeda
Phase 3
300
Seongnam-si, Seoul
2026-05-21
Recruiting
Transition of Care in Pediatric Rare Endocrine Disorders
NCT07786142Endocrine Disorder, Rare Disorders
Seoul National University Hospital
Not applicable
150
Daegu, Daejeon, Gwangju, Hwasun, Incheon, Jeonju, Seongnam, Seoul
2026-05-20
Recruiting
Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot Study
NCT07572032Heart Failure Due to Coronary Artery Disease, Valvular Cardiomyopathy, Heart Failure
DrugSacubitril / Valsartan
Kyungsub Song
Phase 4
80
Daegu, Seongnam-si, Suwon, Seoul
2026-05-20
Recruiting
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
NCT07589595Cognitive Dysfunction, Lewy Body Disease, Synucleinopathies, Amyloid
DrugDonanemab
Eli Lilly and Company
Phase 2
350
Gangnam-gu, Incheon, Namdong-gu, Seoul
2026-05-20
Recruiting
AbbVie
Phase 1
18
Seoul
2026-05-20
Recruiting
Jade Biosciences, Inc.
Phase 2
30
Anyang-si, Seongnam-si, Seoul, Suwon
2026-05-19
Recruiting
Samsung Medical Center
Not applicable
360
Seoul
2026-05-19
Recruiting
Gilead Sciences
Phase 2
170
Busan, Seoul
2026-05-19
Recruiting
Dong-A ST Co., Ltd.
Phase 1
51
Seongnam, Seoul
2026-05-18
Recruiting
AstraZeneca
Phase 1/2
42
Seoul
2026-05-18
Not yet open
Postoperative Insulin Intervention After Pancreatectomy in nDM Patients
NCT07540975Postoperative Hyperglycemia, Pancreatectomy
Dae Wook Hwang
Not applicable
290
Seoul
2026-05-18
Recruiting
PULSAR Combined With Immunotherapy for Unresectable Locally Advanced Gastric Cancer
NCT07607119Gastric Adenocarcinoma, Stomach Neoplasms, Locally Advanced Gastric Cancer, Unresectable Gastric Cancer
Samsung Medical Center
Not applicable
53
Seoul
2026-05-15
Recruiting
A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Autoantibody-Associated Psychiatric Disease
NCT07093333Anti-N-methyl-D-aspartate Receptor (NMDAR) Encephalitis (ANRE), Anti-N-methyl-D-aspartate Receptor (NMDAR) Antibody-associated Psychiatric Disease, Autoimmune Encephalitis
Arialys Australia Pty Ltd
Phase 2
30
Seoul
2026-05-15
Recruiting
Ipsen
Phase 3
350
Seoul, Busan
2026-05-14
Recruiting
Innopeutics Corporation
Phase 1
6
Seoul
2026-05-13
Recruiting
Karolinska Institutet
Not applicable
1,380
Seoul
2026-05-13
By invitation
Digital Phenotypes for Predicting Depression_Validation
NCT07880015Major Depressive Disorder, Bipolar I Disorder, Bipolar II Disorder, Mood Disorders
Korea University Anam Hospital
Observational
200
Seoul
2026-05-13
Recruiting
A Study to Investigate Efficacy and Safety of KP-001 Compared With Placebo in Patients Aged ≥2 Years With Common VM, Common LM, or KTS/CLOVES Syndrome
NCT07285005Venous Malformations, Lymphatic Malformations, Klippel-Trenaunay Syndrome, CLOVES Syndrome
Kaken Pharmaceutical
Phase 3
150
Daegu, Seoul
2026-05-13
Recruiting
Astellas Pharma Global Development, Inc.
Phase 3
390
Daegu, Seongnam-si, Seoul
2026-05-11
Recruiting
Genmab
Phase 2
160
Seoul
2026-05-11
Active, closed
Novartis Pharmaceuticals
Phase 3
5,700
Daegu, Wŏnju, Bundang Gu, Suwon, Incheon, Seoul, Busan, Gwangju
2026-05-11
Recruiting
Ningbo Newbay Technology Development Co., Ltd
Phase 2/3
255
Seongnam-si, Seoul
2026-05-11
By invitation
Duration of Perioperative Antibiotics in Pancreatoduodenectomy
NCT07043855Pancreatoduodenectomy, PPPD, Infectious Complications
DrugCefazolin
Asan Medical Center
Not applicable
558
Seoul
2026-05-11
Recruiting
A Study of PLH-2301 in Subjects With Sarcopenia
NCT07390552Sarcopenia in Elderly
Pluto Inc.
Phase 2
168
Seongnam-si, Suwon, Seoul
2026-05-08
Recruiting
MetaFines
Phase 2
135
Seoul, Gyeonggi-do
2026-05-08
Recruiting
Daewoong Pharmaceutical Co. LTD.
Phase 1
72
Seoul
2026-05-06
Recruiting
Mirati Therapeutics Inc.
Phase 2
170
Goyang-si, Seoul
2026-05-06
Recruiting
EMD Serono Research & Development Institute, Inc.
Phase 3
1,020
Goyang-si, Seongnam-si, Daegu, Seoul
2026-05-06
Recruiting
Regeneron Pharmaceuticals
Phase 2
99
Namdong-gu, Seoul
2026-05-06
Recruiting
AstraZeneca
Phase 3
670
Goyang-si, Seoul
2026-05-04
Recruiting
Merck Sharp & Dohme LLC
Phase 3
876
Goyang-si, Seongnam-si, Suwon, Cheongju-si, Seoul
2026-05-04
Recruiting
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
NCT07519772Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse
DrugMK-1045
Merck Sharp & Dohme LLC
Phase 1/2
280
Seoul
2026-05-03
Recruiting
Seoul National University Hospital
Not applicable
45
Seoul
2026-05-01
Not yet open
Jung-Sun Lee
Not applicable
120
Seoul
2026-05-01
Not yet open
Addpharma Inc.
Phase 1
52
Seoul
2026-05
Not yet open
Onconic Therapeutics Inc.
Phase 1
36
Seoul
2026-05
Not yet open
Yonsei University
Not applicable
60
Seoul
2026-05
Not yet open
Samsung Medical Center
Not applicable
500
Seoul
2026-05
Not yet open
Fexuclue for Prevention of NSAIDs-Induced Peptic Ulcer in Real-World Practice
NCT07558707Peptic Ulcer, NSAID-Induced Peptic Ulcer
Daewoong Pharmaceutical Co. LTD.
Observational
7,000
Seoul
2026-04-30
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
140
Seoul
2026-04-30
Recruiting
AbbVie
Phase 2/3
900
Seoul
2026-04-30
Not yet open
AI-based Customized tDCS for Finger Motor Recovery After Subacute Stroke
NCT07491029Subacute Stroke, Upper Extremity Function
NEUROPHET
Not applicable
116
Seoul
2026-04-30
Not yet open
Daewoong Pharmaceutical Co. LTD.
Observational
12,000
Seoul
2026-04-30
Recruiting
Safety and Effectiveness of Ultrasound-guided Pharmacopuncture for Spinal Diseases
NCT07543692Spinal Disease, Neck Pain, Low Back Pain, Radiculopathy
Jaseng Medical Foundation
Observational
600
Daejeon, Seoul, Bucheon-si, Yangsan
2026-04-29
Recruiting
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
NCT07354074Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, Philadelphia Chromosome Positive
DrugsAsciminib single agent·ABL001
Novartis Pharmaceuticals
Phase 2
50
Seoul
2026-04-28
Recruiting
Bon-Kwon Koo
Not applicable
1,944
Seoul
2026-04-27
Recruiting
Jisu Kim
Not applicable
38
Seoul
2026-04-27
Recruiting
LucasBio
Not applicable
5
Seoul
2026-04-27
Active, closed
Samsung S-Viscosity vs Canon Dispersion Slope in Steatotic Liver Disease (SAVID-SLD)
NCT07530419Metabolic Dysfunction-Associated Steatotic Liver Disease, Fatty Liver, Liver Fibrosis
Seoul National University Hospital
Observational
95
Seoul
2026-04-24
Active, closed
Co-design of an AI Rehabilitation Program for Children With Borderline Intellectual Disorder
NCT07625592Borderline Intellectual Functioning (BIF), Intellectual Disability
Samsung Medical Center
Observational
30
Seoul
2026-04-24
Recruiting
Inhibikase Therapeutics
Phase 3
486
Gwangju, Seoul
2026-04-23
Recruiting
Daewoong Pharmaceutical Co. LTD.
Phase 1
40
Seoul
2026-04-22
Recruiting
BioMarin Pharmaceutical
Phase 2/3
160
Seoul, Yangsan
2026-04-20
Active, closed
Aribio Lab Co., Ltd.
Phase 2
135
Daegu, Seongnam-si, Yongin, Jeonju, Seoul
2026-04-17
Recruiting
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Phase 3
420
Daegu, Goyang-si, Seoul
2026-04-17
Recruiting
Novo Nordisk A/S
Phase 2
270
Ansan-si, Yangsan, Seoul
2026-04-17
Recruiting
LEXURE for Post-Stroke Aphasia
NCT07570264Aphasia
Nunaps Inc
Not applicable
116
Ansan, Busan, Chuncheon, Daegu, Gwangju, Ilsan, Jeonju, Seoul
2026-04-16
Recruiting
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
150
Seongnam-si, Seoul
2026-04-16
Recruiting
Remibrutinib Open Label Roll-over Post-trial Access Protocol
NCT07456891Indication of the Parent Protocol
DrugRemibrutinib
Novartis Pharmaceuticals
Phase 3
650
Daegu, Ansan, Hwaseong-si, Suwon, Dongjak Gu, Seoul, Gwangju, Incheon
2026-04-16
Recruiting
GlaxoSmithKline
Phase 2
200
Seoul, Ulsan
2026-04-15
Recruiting
Eli Lilly and Company
Phase 2
65
Dongjak-gu, Incheon, Jeonju, Seoul
2026-04-14
Recruiting
Scout Dose of Resin Microspheres
NCT07476651Radioembolization, Hepatocellular Carcinoma (HCC), Intrahepatic Cholangiocarcinoma (ICC), Liver Metastasis
Seoul National University Hospital
Not applicable
30
Seoul
2026-04-13
Recruiting
Boehringer Ingelheim
Phase 3
670
Busan, Daejoen, Goyang, Hwasun, Seongnam, Seoul
2026-04-13
Recruiting
JW Pharmaceutical
Phase 1
104
Seoul
2026-04-13
Active, closed
Novo Nordisk A/S
Phase 3
638
Seoungnam-si, Gwangju, Seoul
2026-04-13
Recruiting
Danicopan PMS in Korea
NCT07457151Paroxysmal Nocturnal Hemoglobinuria
AstraZeneca
Observational
27
Busan, Hwasun-gun, Seoul
2026-04-10
Recruiting
Merck Sharp & Dohme LLC
Phase 3
758
Seoul
2026-04-09
Recruiting
Incyte Corporation
Phase 3
588
Goyang-si, Seongnam-si, Seoul
2026-04-09
Recruiting
AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors
NCT07403721Metastatic or Locally Advanced Solid Tumors With Microsatellite Instability-high (MSI-H) or Mismatched Repair Deficiency (dMMR)
Amgen
Phase 1
464
Seoul
2026-04-08
Recruiting
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
NCT07519655Non-Small-Cell Lung, Esophageal Cancer, Cutaneous Melanoma
Pfizer
Phase 1
250
Seoul
2026-04-08
Recruiting
Hoffmann-La Roche
Phase 2
80
Dongnam-gu, Cheonan-si, Namdong-Gu, Seongnam-si, Seoul
2026-04-07
Recruiting
Comparing Implant Retention Versus Removal for MRONJ at Implant Sites
NCT07435259Medication Related Osteonecrosis of the Jaw
Kyunghee University Dental Hospital
Not applicable
50
Seoul
2026-04-06
Active, closed
Evaluate the Safety and Efficacy of TJO-087
NCT07810972Dry Eye Syndrome (DES)
Taejoon Pharmaceutical Co., Ltd.
Phase 2
90
Seoul
2026-04-06
Recruiting
AI-Based Phenome Data Analysis for Predicting the Onset of Major Diseases
NCT07595718Diabetes Mellitus Type 2, Breast Neoplasms, Low Back Pain, Osteoarthritis
Jae Yong Jeon, MD
Observational
1,000
Seoul
2026-04-02
Recruiting
EMD Serono Research & Development Institute, Inc.
Phase 3
202
Seoul, Seongnam-si
2026-04-01
Recruiting
Seoul National University Hospital
Not applicable
96
Seoul
2026-04-01
Recruiting
A Phase 2/3 Study on the Efficacy and Safety of Mangaciclanol for Contrast-Enhanced MRI of CNS or Body in Adult Patients
NCT07472491Known or Highly Suspected Central Nervous System (CNS) Lesion, Known or Highly Suspected Body (Excluding CNS) Lesion
DrugGadobutrol
GE Healthcare
Phase 2/3
640
Seoul
2026-04-01
Recruiting
Seoul National University Hospital
Observational
150
Seoul
2026-04-01
Not yet open
Addpharma Inc.
Phase 1
50
Seoul
2026-04
Not yet open
Daewoong Pharmaceutical Co. LTD.
Phase 4
360
Seoul
2026-04
Not yet open
Moogene Medi Co., Ltd
Phase 1/2
30
Seoul
2026-04
Not yet open
Korea United Pharm. Inc.
Phase 1
44
Seoul
2026-04
Not yet open
Addpharma Inc.
Phase 1
70
Seoul
2026-04
Not yet open
Yonsei University
Phase 4
538
Seoul
2026-04
Not yet open
Asan Medical Center
Phase 2
146
Seoul
2026-04
Recruiting
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
NCT07462377Epidermal Growth Factor, Epidermal Growth Factor Receptor, Epidermal Growth Factor Receptor Gene Mutation, Non Small Cell
EpiBiologics
Phase 1
110
Seoul
2026-03-31
Recruiting
AstraZeneca
Phase 1
40
Seongnam-si, Seoul
2026-03-31
Recruiting
Routine Probe Compression After Transrectal Prostate Biopsy(RPCAB) to Reduce Bleeding and Infectious Complications
NCT07550985Prostate Biopsy, Post Biopsy Bleeding, Transrectal Ultrasound-guided Prostate Biopsy
Veterans Health Service Medical Center, Seoul, Korea
Not applicable
324
Seoul
2026-03-30
Recruiting
BioNTech SE
Phase 1/2
533
Seongnam, Seoul
2026-03-30
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
60
Goyang-si, Seoul
2026-03-27
Recruiting
Konkuk University Medical Center
Phase 4
100
Seoul
2026-03-27
Recruiting
A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
NCT07146906Immunoglobulin A Nephropathy (IgAN)
DrugZigakibart
Novartis Pharmaceuticals
Phase 2
32
Seoul
2026-03-26
Recruiting
Eisai Inc.
Phase 2
64
Seongnam-si, Daegu, Seoul, Suwon
2026-03-26
Recruiting
Bristol-Myers Squibb
Phase 1/2
474
Seoul
2026-03-26
Recruiting
Yuhan Corporation
Phase 2
150
Gyeonggi-do, Daegu, Seoul, Yangsan, Incheon
2026-03-26
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
NCT07415044Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe
DrugZotemtegrast
Eli Lilly and Company
Phase 2
1,431
Busan, Daegu, Daejeon, Gwangju, Gyeongsan-si, Pusan, Seoul, Wŏnju
2026-03-26
By invitation
Samsung Medical Center
Not applicable
36
Seoul
2026-03-26
Recruiting
Merck Sharp & Dohme LLC
Phase 2
100
Wŏnju, Ansan-si, Seoul
2026-03-24
Recruiting
Novartis Pharmaceuticals
Phase 3
770
Daejeon, Dongjak Gu, Seoul, Busan
2026-03-24
Recruiting
A Study of ITC-6146RO in Patients With Advanced or Metastatic Cancer Who Have Failed Standard Therapy
NCT07423117Metastatic Castration-resistant Prostate Cancer, Non-small Cell Lung Cancer, Triple Negative Breast Cancer, Metastatic Solid Tumor
IntoCell, Inc
Phase 1
102
Seoul
2026-03-24
By invitation
BioMe Inc.
Not applicable
38
Seoul
2026-03-23
Recruiting
Boehringer Ingelheim
Phase 2
132
Seoul, Suwon
2026-03-23
Recruiting
Il-Yang Pharm. Co., Ltd.
Phase 1
86
Seoul
2026-03-23
Recruiting
Hoffmann-La Roche
Phase 3
1,600
Seongnam-si, Daejeon, Gangwon-do, Gwangju, Gyeonggi-do, Seoul
2026-03-23
Recruiting
Samsung Bioepis Co., Ltd.
Phase 1
149
Seoul
2026-03-23
Recruiting
Merck Sharp & Dohme LLC
Phase 3
450
Gangnam, Seodaemun-gu, Seoul
2026-03-23
Active, closed
EverEx Inc.
Not applicable
156
Guri-si, Gwangmyeong, Uijeongbu-si, Seoul
2026-03-19
Recruiting
Samsung Medical Center
Not applicable
2,100
Seoul, Busan, Changwon, Daegu, Gwangju, Gwangmyeong, Gyeonggi-do, Iksan
2026-03-18
Recruiting
Merck Sharp & Dohme LLC
Phase 3
400
Goyang-si, Suwon, Daegu, Seoul
2026-03-18
Recruiting
AstraZeneca
Phase 1/2
180
Seoul
2026-03-17
Active, closed
Video Conference-Based Brief Cognitive Behavioral Therapy for Suicidal High-Risk Outpatients With Mood Disorders
NCT07395817Suicidal Ideation and Behaviors, Suicide Attempt, Cognitive Behavioral Therapy
Hyung Keun Park
Not applicable
40
Seoul
2026-03-16
Recruiting
Asan Medical Center
Phase 2
33
Seoul
2026-03-16
Recruiting
Hoffmann-La Roche
Phase 3
2,000
Daegu, Seongnam-si, Daejeon, Gwangju, Gyeonggi-do, Incheon, Seoul
2026-03-16
Recruiting
Bristol-Myers Squibb
Phase 3
850
Cheongju-si, Seongnam, Seoul
2026-03-16
Recruiting
Bristol-Myers Squibb
Phase 1/2
198
Seongnam-si, Seoul
2026-03-16
Not yet open
Regorafenib After Treatment Failure of First Line Immune Checkpoint Inhibitor Treatment in Advanced Hepatocellular Carcinoma Patients
NCT07514455Carcinoma, Hepatocellular, Hepatic Insufficien, Disease Progression, Treatment Failure
DrugRegorafenib
Ju Hyun Shim
Phase 2
20
Seoul
2026-03-15
Not yet open
Regorafenib After Failure of Lenvatinib in Patients With Unresectable HCC: The RELEVANT-HCC Trial
NCT07514429Carcinoma, Hepatocellular, Lenvatinib, Treatment Failure
DrugRegorafenib
Ju Hyun Shim
Phase 2
24
Seoul
2026-03-15
Recruiting
Bristol-Myers Squibb
Phase 2/3
690
Seongnam, Seoul
2026-03-13
Recruiting
Effect of EIT-guided PEEP in ARDS Patients
NCT06990477ARDS (Acute Respiratory Distress Syndrome)
Southeast University, China
Not applicable
2,400
Seoul
2026-03-13
Recruiting
Bristol-Myers Squibb
Phase 3
750
Busan, Seoul, Deagu, Junggu
2026-03-12
Recruiting
Astellas Pharma Global Development, Inc.
Phase 2
240
Seongnam-si, Hwasun, Gyeonggi-do, Seoul
2026-03-12
Active, closed
Sanofi
Phase 3
59
Seoul
2026-03-12
Recruiting
Hoffmann-La Roche
Phase 2
100
Seongnam-si, Seoul
2026-03-11
Recruiting
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
NCT07332481Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE)
DrugEnpatoran
EMD Serono Research & Development Institute, Inc.
Phase 3
202
Ansan-si, Seongnam-si, Incheon, Seoul
2026-03-10
Not yet open
AI-based Rehabilitation for Hip and Knee Surgery Patients
NCT07505628Total Knee Arthroplasty, Total Hip Arthroplasty (THA), Hip Fracture Surgery
Gangnam Severance Hospital
Not applicable
106
Seoul
2026-03-09
Recruiting
Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
NCT07491445Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma
DrugsCetuximab·Nab-paclitaxel·Gemcitabine
Revolution Medicines, Inc.
Phase 3
900
Daegu, Busan, Seoul
2026-03-09
Recruiting
Sin Gon Kim
Not applicable
2,186
Seoul
2026-03-09
Recruiting
INSIGHT-PCa: MRI- and PHI-Guided Risk-Adapted Strategy for Prostate Cancer Diagnosis
NCT07398690Prostate Cancer (Diagnosis), Prostate Cancer
In Gab Jeong, MD
Not applicable
1,432
Seoul
2026-03-09
Recruiting
Samsung Medical Center
Phase 3
270
Seoul
2026-03-06
Recruiting
AusperBio Therapeutics Inc.
Phase 2
84
Seoul
2026-03-06
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Busan, Gwangju, Gyeonggi-do, Seoul, Suwon
2026-03-05
Recruiting
Incyte Corporation
Phase 3
700
Changwon-si, Goyang-si, Seongnam, Seongnam-si, Seoul, Suwon
2026-03-05
Recruiting
BicycleTx Limited
Phase 2
39
Seoul
2026-03-05
Recruiting
Janssen Research & Development, LLC
Phase 1/2
60
Seoul
2026-03-03
Active, closed
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
NCT07288398Pulmonary Hypertension Associated With HFpEF
DrugTNX-103
Tenax Therapeutics, Inc.
Phase 3
540
Cheongju-si, Gwangju, Incheon, Seoul, Wŏnju
2026-03-03
Not yet open
Doxycycline vs. Macrolide for MRMP (DOMINO)
NCT07306234Mycoplasma Pneumoniae, Mycoplasma Pneumoniae Pneumonia
DrugsDoxycycline·Azithromycin
Young June Choe
Phase 4
208
Busan, Changwon, Gwangju, Jeju City, Seongnam, Seoul
2026-03-01
Not yet open
Korea Acute Myocardial Infarction Registry
NCT07409441Myocardial Infarction, Acute
Samsung Medical Center
Observational
20,000
Gwangju, Seoul
2026-03-01
Recruiting
Yonsei University
Phase 2
78
Seoul
2026-03
Not yet open
Chong Kun Dang Pharmaceutical
Phase 4
200
Seoul
2026-03
Not yet open
Samsung Medical Center
Phase 1
12
Seoul
2026-03
Not yet open
Samsung Medical Center
Phase 4
60
Seoul
2026-03
Not yet open
Drug Coated Balloon vs. Drug-eluting Stent in Patients With Coronary Artery Disease
NCT07442500Coronary Artery Disease, Percutaneous Coronary Intervention (PCI)
Samsung Medical Center
Observational
470,000
Seoul
2026-02-28
Not yet open
Onconic Therapeutics Inc.
Phase 1/2
49
Seoul
2026-02-27
Not yet open
Onconic Therapeutics Inc.
Phase 2
81
Seoul
2026-02-27
Recruiting
Addpharma Inc.
Phase 1
44
Seoul
2026-02-26
Recruiting
Trastzumab Deruxtecan Versus SOC in Recurrent Ovarian That Progressed on Prior PARP Inhibitor Therapy
NCT07340164Ovarian Cancer, Ovarian Carcinoma, Recurrent, Ovarian Cancer Metastatic Recurrent, Ovarian Cancer (OvCa)
DrugsTrastuzumab deruxtecan·Bevacizumab
Yonsei University
Phase 2
116
Seoul
2026-02-26
Recruiting
Eulji University Hospital
Not applicable
96
Seoul
2026-02-23
Recruiting
CLASSYS Inc.
Not applicable
96
Seoul
2026-02-23
Recruiting
AstraZeneca
Phase 3
508
Seoul
2026-02-23
Recruiting
CKD Bio Corporation
Not applicable
60
Gyeonggi-do, Seoul
2026-02-23
Not yet open
Consistency of ASIS Line vs. Tuffier's Line for Lumbar Level Identification
NCT07396961Spinal Anesthesia Evaluation, Lumbar Vertebrae
Kangbuk Samsung Hospital
Observational
140
Suwon, Seoul
2026-02-20
Active, closed
Seoul National University Hospital
Not applicable
124
Seoul
2026-02-20
Active, closed
Seoul National University Bundang Hospital
Not applicable
60
Seoul, Seongnam-si
2026-02-19
Not yet open
Risk Prediction Model for Older Adults Undergoing Noncardiac Surgery
NCT07409467Major Noncardiac Surgery, Geriatric Anesthesia, Postoperative Complications
Seoul National University Hospital
Observational
520
Seoul
2026-02-19
Recruiting
Efficacy of Early Rhythm Control in AF With TR Patients
NCT07607093Atrial Fibrillation (AF), Tricuspid Regurgitation (TR)
Samsung Medical Center
Observational
5,800
Seoul
2026-02-18
Recruiting
Crescent Biopharma, Inc.
Phase 1/2
540
Songpa-dong, Seongnam-si, Seoul
2026-02-17
Recruiting
Astellas Pharma Global Development, Inc.
Phase 3
614
Cheongju-si, Incheon, Seongnam-si, Seoul, Suwon
2026-02-17
Recruiting
Merck Sharp & Dohme LLC
Phase 3
900
Seodaemun-Gu, Daegu, Seoul
2026-02-16
Recruiting
Boehringer Ingelheim
Phase 3
286
Busan, Gangnam-gu, Goyang, Seoul, Suwon
2026-02-16
Not yet open
Asan Medical Center
Observational
600
Seoul
2026-02-15
Recruiting
Hanmi Pharmaceutical Company Limited
Phase 2
45
Seongnam-si, Hwasun, Busan, Daegu, Daejeon, Seoul
2026-02-12
Not yet open
Discontinuation of Antiplatelet Therapy After Drug-Coated Balloon Treatment
NCT07398001Percutaneous Coronary Intervention, Antiplatelet Therapy, Drug-coated Balloon
Ulsan University Hospital
Not applicable
1,042
Ansan, Chuncheon, Pusan, Seoul, Ulsan
2026-02-12
Not yet open
Samsung Medical Center
Observational
235,342
Seoul
2026-02-12
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
24
Suwon, Seoul
2026-02-11
Recruiting
Pfizer
Phase 2/3
1,156
Jeonju, Seoul
2026-02-11
Recruiting
ViiV Healthcare
Phase 2
186
Daegu, Gwangju, Pusan, Seoul
2026-02-11
Recruiting
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
NCT07201922Familial Pulmonary Fibrosis, Interstitial Lung Abnormalities, Interstitial Lung Diseases
DrugNerandomilast
Boehringer Ingelheim
Phase 3
80
Seoul
2026-02-10
Recruiting
Eli Lilly and Company
Phase 3
800
Ansan-si, Seoul
2026-02-10
Recruiting
LucasBio
Not applicable
6
Seoul
2026-02-10
Recruiting
GlaxoSmithKline
Phase 1/2
54
Seoul
2026-02-10
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
55
Seoul
2026-02-09
Recruiting
Eli Lilly and Company
Phase 3
1,000
Ansan-si, Gwangju, Jeju City, Seoul
2026-02-09
Recruiting
Eli Lilly and Company
Phase 3
900
Daegu, Dongjak-gu, Seoul, Uijeongbu-si
2026-02-09
Not yet open
Impact of Conversational Approaches in Pediatric Social Robot-Mediated Interventions
NCT07389902Pediatric Patients, Pediatric Patients in Hospital Settings, Hospitalized Children
Samsung Medical Center
Not applicable
60
Seoul
2026-02-09
Active, closed
Janssen Research & Development, LLC
Phase 2
168
Jeollanam-do, Seoul
2026-02-08
Recruiting
Eli Lilly and Company
Phase 3
1,980
Namdong-gu, Seogu, Seongnam, Seoul, Yangsan
2026-02-06
Recruiting
A Self-Instructional Online Program for Early Childhood and Elementary Teachers Supporting Autistic Children and Children With Developmental Delays
NCT07524192Autism Spectrum Disorder, Developmental Disabilities, Developmental Delay, Teacher Training
Boin Choi
Not applicable
70
Seoul
2026-02-05
Recruiting
A Phase I/IIa Clinical Trial to Investigate BVAC-E6E7 in Subjects With HPV Positive HNSCC.
NCT06797986Head and Neck Squamous Cell Carcinoma (HNSCC), HPV (Human Papillomavirus)-Associated Carcinoma, HPV Positive Oropharyngeal Squamous Cell Carcinoma
Cellid Co., Ltd.
Phase 1/2
37
Seoul
2026-02-04
Recruiting
JW Pharmaceutical
Phase 3
254
Seoul
2026-02-03
Recruiting
AstraZeneca
Phase 3
2,130
Daegu, Hwasun-gun, Seongnam-si, Seoul
2026-02-03
Recruiting
Alnylam Pharmaceuticals
Phase 3
125
Seoul
2026-02-03
By invitation
Ewha Womans University Mokdong Hospital
Not applicable
200
Seoul
2026-02-02
Recruiting
Samsung Medical Center
Observational
800,000
Seoul
2026-02-02
Recruiting
Asan Medical Center
Not applicable
70
Seoul
2026-02-02
Not yet open
Comparison of the Diagnosis Time of VET and SCL in Patients With Intraoperative Coagulopathy
NCT06637943Arthritis of Knee, Arthritis of Hip, Spine, Prostate Cancer
Konkuk University Medical Center
Observational
210
Seoul
2026-02-01
Recruiting
Evaluation of Mixed Reality Cardiopulmonary Resuscitation Training
NCT07363772Cardiopulmonary Resuscitation (CPR), Basic Life Support Training Course, Cardiac Arrest (CA)
Seoul National University Hospital
Not applicable
120
Seoul
2026-02-01
Not yet open
Enteral Versus Parenteral Nutrition During Recovery After Shock
NCT07411014Shock, Critical Illness, Nutritional Support, Vasopressor Therapy
Samsung Medical Center
Not applicable
1,150
Seoul
2026-02-01
Recruiting
Samsung Medical Center
Observational
150
Seoul
2026-02-01
Not yet open
Clinical Study to Evaluate the Safety and Anti-Tumor Activity of AB-201
NCT07333820Malignant Neoplasm of Stomach, Unspecified
Yonsei University
Phase 1
18
Seoul
2026-02
Not yet open
Yonsei University
Not applicable
4,400
Seoul
2026-02
Recruiting
Genmab
Phase 2
240
Cheongju-si, Daegu, Incheon, Seoul, Suwon
2026-01-30
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
170
Seoul
2026-01-29
Recruiting
SANGMYUNG innovation
Phase 3
312
Seoul
2026-01-29
Recruiting
Kymera Therapeutics, Inc.
Phase 2
264
Gyeonggi-do, Seoul
2026-01-28
Active, closed
GC Biopharma Corp
Phase 1
72
Seoul
2026-01-28
Recruiting
Asan Medical Center
Not applicable
100
Seoul
2026-01-28
Recruiting
Addpharma Inc.
Phase 1
46
Seoul
2026-01-27
Not yet open
Addpharma Inc.
Phase 1
41
Seoul
2026-01-27
Recruiting
Seoul National University Hospital
Observational
21
Seoul
2026-01-27
Recruiting
FutureChem
Phase 3
114
Gyeonggi-do, Seoul, Suwon
2026-01-26
Recruiting
AbbVie
Phase 2
165
Busan, Bucheon-si, Seongnam-si, Seoul
2026-01-23
Not yet open
Addpharma Inc.
Phase 1
55
Seoul
2026-01-23
By invitation
Samsung Medical Center
Not applicable
12
Seoul
2026-01-23
Recruiting
Sanofi
Phase 3
751
Busan, Gwangju, Seoul
2026-01-22
Recruiting
BeOne Medicines
Phase 3
500
Seongnam-si, SeochoGu, SeodaemunGu, Seoul, SongpaGu
2026-01-22
Recruiting
Samsung Medical Center
Observational
1,000
Seoul
2026-01-22
Active, closed
Jetema Co., Ltd.
Not applicable
100
Cheonan, Seoul
2026-01-21
Recruiting
Argon Plasma Coagulation Versus Endoscopic Mucosal Resection for Gastric Adenoma (CLER-GA)
NCT07161479Gastric Adenoma, Stomach Neoplasms, Precancerous Conditions, Dysplasia Stomach
Samsung Medical Center
Not applicable
160
Goyang-si, Seoul
2026-01-20
Recruiting
Eikon Therapeutics
Phase 1/2
160
Busan, Seoul, Suwon
2026-01-20
By invitation
NVP Healthcare
Not applicable
60
Seoul
2026-01-20
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,023
Goyang-si, Jongno-gu, Seodaemun-Gu, Seoul
2026-01-19
Recruiting
Sanofi
Phase 3
751
Ansan-si, Busan, Daegu, Seoul, Suwon
2026-01-16
Recruiting
Boehringer Ingelheim
Phase 3
400
Goyang, Seongnam, Seoul, Suwon
2026-01-16
Recruiting
Servier Bio-Innovation LLC
Phase 1
30
Seongnam-si, Seoul
2026-01-14
By invitation
Jaseng Medical Foundation
Not applicable
40
Seoul
2026-01-13
Recruiting
Novartis Pharmaceuticals
Phase 1/2
181
Seoul
2026-01-13
Recruiting
Epibiotech
Phase 1/2
42
Seoul
2026-01-12
Recruiting
STCube, Inc.
Phase 2
62
Gyeonggi-do, Seoul
2026-01-10
Recruiting
AstraZeneca
Phase 1/2
85
Seoul
2026-01-09
Recruiting
Contineum Therapeutics
Phase 2
324
Seoul, Bucheon-si, Seongnam-si, Songpa-dong, Incheon
2026-01-08
Not yet open
Seoul St. Mary's Hospital
Not applicable
116
Seoul
2026-01-08
Recruiting
Insmed Incorporated
Phase 3
344
Incheon, Seoul, Wŏnju
2026-01-07
Active, closed
Venous Closure System After AF Ablation
NCT07814144Atrial Fibrillation
Yonsei University
Phase 4
90
Seoul
2026-01-06
Recruiting
Seoul St. Mary's Hospital
Phase 4
68
Seoul
2026-01-06
Recruiting
siRNAgen Therapeutics Inc.
Phase 1
30
Seoul
2026-01-05
Recruiting
Neumous Inc.
Not applicable
10
Seoul
2026-01-05
Rows per page Showing 1–500 of 2859
1 2 3 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a South Korean investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 November 2026. https://priyalifescience.com/clinical-trials-south-korea/city/seoul

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in South Korea and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,401 studies in total at the last sync on 13 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 2,859 of those studies with a site in Seoul.

How many clinical trials are recruiting in Seoul?

1,555 of the 2,859 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:18 UTC sync. A further 209 have not yet opened recruitment, 1,015 are active but closed to new participants, and 80 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Seoul), 2,859 studies
PhaseStudiesRecruitingShare
Phase 391541032%
Observational42428614.8%
Phase 241921014.7%
Not applicable41023714.3%
Phase 12601349.1%
Phase 1/22501708.7%
Phase 4114684%
Phase 2/367402.3%

Most active sponsors

Lead sponsors with the most studies (Seoul)
Lead sponsorStudiesRecruiting
AstraZeneca19791
Seoul National University Hospital184118
Yonsei University14899
Samsung Medical Center14797
Merck Sharp & Dohme LLC11464
Novartis Pharmaceuticals8841
Janssen Research & Development, LLC8130
Hoffmann-La Roche7030
Asan Medical Center6945
AbbVie6221
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.